An Evaluation of Diabetes-Related Measures of Control After 6 Months of Clinical Pharmacy Specialist Intervention

Abstract

Six months of pharmacist intervention resulted in improvement in patients achieving ADA and VA performance measure goals individually and in combination.

Maintenance of Goal Blood Pressure, Cholesterol, and A1C Levels in Veterans With Type 2 Diabetes After Discharge From a Pharmacist-Managed Ambulatory Care Clinic

“…With regard to people with diabetes in particular, a large evidence base exists supporting improvement in A1C and CVD outcomes with pharmacist care ( 11 – 15 ). These retrospective studies have shown reductions in A1C ranging from 1.4 to 3.4 percentage points and an improvement of ∼30% in the number of patients reaching an A1C <7%.…”

Designing a resident research program

“…Posters have been presented at meetings for groups such as ACCP, the American Society of Nephrology, the Academy of Managed Care Pharmacy, and the College of Psychiatric and Neurologic Pharmacists. 21 [25][26][27][28][29][30] These publications feature clinical or practicebased research, and have showcased the work of 48% of residents since the inception of the RRAB.…”

Integration of pharmacists into team-based ambulatory care practice models

“…[3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19][20][21][22] Despite this available information, practitioners are still encountering difficulties and have lingering questions about the most effective techniques for promoting the success of a new service. Practical advice from successful pharmacists can add to the existing literature on this topic and provide useful guidance to practitioners embarking on this journey.…”